نتایج جستجو برای: exemestane

تعداد نتایج: 576  

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2008
M M Regan O Pagani B Walley R Torrisi E A Perez P Francis G F Fleming K N Price B Thürlimann R Maibach M Castiglione-Gertsch A S Coates A Goldhirsch R D Gelber

BACKGROUND The role of chemotherapy in addition to combined endocrine therapy for premenopausal women with endocrine-responsive early breast cancer remains an open question, yet trials designed to answer it have repeatedly failed to adequately accrue. The International Breast Cancer Study Group initiated two concurrent trials in this population: in Premenopausal Endocrine Responsive Chemotherap...

Journal: :Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2016

Journal: :Journal of the National Comprehensive Cancer Network : JNCCN 2013
Josh Lauring Ben Ho Park Antonio C Wolff

The phosphoinositide-3-kinase (PI3-kinase)-Akt-mTOR pathway is a central signal transduction pathway that regulates many critical aspects of normal and cancer physiology, including cell proliferation, apoptosis, cell morphology and migration, protein synthesis, and integration of metabolism. In breast cancer, somatic mutations that activate the pathway occur in more than 50% of tumors, undersco...

Journal: :Hormone research in paediatrics 2010
Sandy A van Gool Jan M Wit Tineke De Schutter Nora De Clerck Andreï A Postnov Sandra Kremer Hovinga Jaap van Doorn Sergio J Veiga Luis Miguel Garcia-Segura Marcel Karperien

BACKGROUND Aromatase inhibition has been proposed as a potential approach for growth enhancement in children with short stature, but detailed animal studies are lacking. AIM To assess the effect and potential adverse effects of aromatase inhibition on growth in female rats. METHODS Prepubertal Wistar rats received intramuscular injections with placebo or the aromatase inhibitor exemestane a...

2013
Abhinav Iyengar Dawn Sheppard

A previously healthy 79-year-old female was referred to hematology for further evaluation of erythrocytosis. Two years earlier she had been diagnosed with ER/PR-positive ductal carcinoma of the breast and was receiving hormonal therapy with exemestane. No secondary cause of erythrocytosis was identified. Serum erythropoietin (EPO) level was normal, and molecular testing for the JAK2 V617F and e...

Journal: :Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2015
J Félix J Almeida D Ferreira S Rabiais B Vandewalle

Cost-effectiveness of everolimus+exemestane as compared to fulvestrant was assessed in terms of the incremental cost per life year (LY) gained, from a Portuguese National Health Service (NHS) perspective. Next to main therapeutic drug costs, other healthcare costs included costs for medical visits, complementary diagnostic procedures, surgery, inpatient visits, additional therapy and end-of-lif...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید